Filtered By:
Condition: Heart Failure

This page shows you your search results in order of date. This is page number 13.

Order by Relevance | Date

Total 576 results found since Jan 2013.

Machine Learning Helps Predict Risk of Heart Failure in Patients with Diabetes
Researchers from Brigham and Women’s Hospital and UT Southwestern Medical center have developed a new machine learning algorithm that predicts the risk of heart failure hospitalization for people suffering from type 2 diabetes. Their work demonstra...
Source: Medgadget - September 19, 2019 Category: Medical Devices Authors: Siavash Parkhideh Tags: Cardiology Informatics Medicine Source Type: blogs

Material to Repair Cardiac Tissue Damaged by Heart Attacks Passes First Clinical Trial
Ventrix, a spin-off company of the University of California San Diego, has developed a special hydrogel that can be injected into the heart to provide a platform for cardiac repair following a heart attack. The technology was just tested in humans fo...
Source: Medgadget - September 17, 2019 Category: Medical Devices Authors: Medgadget Editors Tags: Cardiac Surgery Cardiology Materials Source Type: blogs

Digoxin in Heart failure: Foxglove blossoms again, please don ’ t crush it this time!
William Withering the British Botanist of 18th century now laid to rest in the St Barthomlew Churchyard ,Edgbaston is known for his astonishing isolation of the wonder moelcule Digoxin from Foxglove. (Of course, let us not forget original old lady Ms. Hutton from Shropshire who was treating epidemic dropsy with a concoction of herbal Tea ) He reported this in the seminal paper “An account of Foxglove’ in the year 1750 and subsequently became a fellow of Royal college of science. (The story of Withering and Digoxin is extensively researched and written by Dr Dennis M, Krikler in a classic review article of 198...
Source: Dr.S.Venkatesan MD - September 14, 2019 Category: Cardiology Authors: dr s venkatesan Tags: cardiac failure history of cardiology dig trial radiance proved history of digoxin Source Type: blogs

Chronic coronary syndrome
Chronic coronary syndrome (CCS) is the new name representing stable coronary artery disease as per the new European Society of Cardiology guideline [1]. Six important subcategories of CCS have been outlined: Suspected coronary artery disease with stable anginal symptoms and or dyspnea (anginal equivalent) New onset heart failure or left ventricular dysfunction and suspected coronary artery disease Asymptomatic and symptomatic patients with stabilized symptoms less than 1 year after an acute coronary syndrome or patients with recent revascularization Asymptomatic and symptomatic patient more than 1 year after initial dia...
Source: Cardiophile MD - September 9, 2019 Category: Cardiology Authors: Prof. Dr. Johnson Francis Tags: Cardiology Source Type: blogs

Barostim Neo Neuromodulation Device for Heart Failure Wins FDA Approval
CVRx, a Minneapolis, Minnesota company, won FDA approval for the first neuromodulation device designed to address heart failure. Intended as a treatment option for patients with an ejection fraction ≤35% and New York Heart Failure Classification of...
Source: Medgadget - August 27, 2019 Category: Medical Devices Authors: Medgadget Editors Tags: Cardiac Surgery Cardiology Vascular Surgery Source Type: blogs

Landmark Results Achieved in Aging and Chronic Disease: Danish Group Extends Disease-free Life by 8 Years
By WILLIAM H. BESTERMANN JR., MD New Scientific Breakthroughs Can Provide a Longer Healthier Life Twenty-one years of follow-up comparing usual care with a protocol-driven team-based intervention in diabetes proved that healthy life in humans can be prolonged by 8 years. These results were achieved at a lower per patient per year cost. Aging researchers have been confident that we will soon be able to prolong healthy life. This landmark study shows this ambitious goal can be achieved now with lifestyle intervention and a few highly effective proven medications. These medications interfere with the core molecular biol...
Source: The Health Care Blog - July 11, 2019 Category: Consumer Health News Authors: Christina Liu Tags: Medical Practice Patients aging chronic disease Denmark Diabetes William Bestermann Source Type: blogs

BIOTRONIK Releases BIOMONITOR III Injectable Cardiac Monitor
BIOTRONIK is releasing a new version of its popular BIOMONITOR injectable cardiac monitor. The BIOMONITOR III is less than half the size of the BIOMONITOR 2, while offering much clearer signal quality. It is designed to be injected under the s...
Source: Medgadget - June 28, 2019 Category: Medical Devices Authors: Medgadget Editors Tags: Cardiac Surgery Cardiology Source Type: blogs

Predictors of heart failure in diabetes mellitus
Patients with diabetes mellitus are more prone to develop heart failure than others. Features of diabetes mellitus associated with the development of heart failure are: Poor glycemic control Longer duration of diabetes mellitus Diabetes on insulin treatment Presence of microvascular complications like retinopathy or nephropathy Reference Verma S, McMurray JJV. The Serendipitous Story of SGLT2 Inhibitors in Heart Failure. New Insights From DECLARE-TIMI 58. Circulation. 2019;139:2542–2553.
Source: Cardiophile MD - June 4, 2019 Category: Cardiology Authors: Prof. Dr. Johnson Francis Tags: Cardiology Source Type: blogs

Medical Societies Side with ABIM at the Expense of Their Members
Yesterday in a coordinated blow, the American College of Cardiology (ACC), Heart Rhythm Society (HRS), Society for Cardiovascular Interventions (SCAI), the Heart Failure Society of America (HFSA), and the American Board of Internal Medicine (ABIM) turned to their marketing muscle, funded in large part by the medical device industry, to issue a joint letter to their respective physician
Source: Dr. Wes - May 29, 2019 Category: Cardiology Authors: Westby G. Fisher, MD Source Type: blogs

Atrial functional mitral regurgitation
Atrial functional mitral regurgitation (MR) has been featured as the JACC Review Topic of the Week [1]. Atrial functional MR is due to isolated mitral annular dilatation with insufficient leaflet growth and impaired annular dynamics. It occurs typically in atrial fibrillation and heart failure with preserved ejection fraction (HFpEF). It is different from MR secondary to left ventricular dysfunction. In left ventricular dysfunction, tethering of mitral leaflets is an important cause for mitral regurgitation while it is not so in atrial functional MR. Hence MR secondary to left ventricular dysfunction is usually an eccent...
Source: Cardiophile MD - May 21, 2019 Category: Cardiology Authors: Prof. Dr. Johnson Francis Tags: Cardiology Source Type: blogs

Diagnostic criteria for peripartum cardiomyopathy
Diagnostic criteria for peripartum cardiomyopathy are: Development of heart failure in the last month of pregnancy or within 5 months after delivery Left ventricular systolic dysfunction with ejection fraction less than 45% No other identifiable cause for heart failure No recognized heart disease before the last month of pregnancy Reference van Spaendonck-Zwarts KY1, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, Dooijes D, van den Berg MP. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation. 2010 May 25;121(20):2169-75.
Source: Cardiophile MD - May 21, 2019 Category: Cardiology Authors: Prof. Dr. Johnson Francis Tags: Cardiology Source Type: blogs

SGLT2 inhibitors and GLP-1 receptor agonists for diabetics with heart failure
Sodium glucose cotransporter 2 inhibitors  (SGLT2-i) and glucagon-like peptide-1 receptor agonists (GLP-1 RA) are two new promising classes of anti diabetic medications which can reduce hospitalizations for heart failure. American Diabetes Association and the European Association for the Study of Diabetes consensus report published in 2018 endorses this view [1]. The statement mentions that those with heart failure should preferably be treated with SGLT-is and if this is not feasible either due to intolerance or inadequate estimated glomerular filtration rate, GLP-1 RA should be used. It may be noted that published data...
Source: Cardiophile MD - May 21, 2019 Category: Cardiology Authors: Prof. Dr. Johnson Francis Tags: Cardiology Source Type: blogs

The benefits of compassion always outweigh its risks
It was an ordinary afternoon in my outpatient internal medicine rotation. I prepared to enter a room for a congestive heart failure hospital follow-up patient. I mentally prepared myself. I was going to ask for his hospital records (particularly looking for the echocardiogram), make sure he was started on an ACE inhibitor and a beta-blocker, […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.
Source: Kevin, M.D. - Medical Weblog - May 14, 2019 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/nidhi-desai" rel="tag" > Nidhi Desai < /a > < /span > Tags: Education Cardiology Primary Care Source Type: blogs

It ’s time we approach heart failure like cancer
“I’m sorry, Mr. Smith. Your heart is very sick, and your body has irreversible damage. It’s too dangerous to attempt a transplant or implant a heart pump. There’s nothing more we can do.” I’ve encountered this scenario more often than I care to admit as a cardiac surgeon that treats adva nced heart failure. Tragically, many […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.
Source: Kevin, M.D. - Medical Weblog - May 10, 2019 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/brian-lima" rel="tag" > Brian Lima, MD < /a > < /span > Tags: Conditions Cardiology Source Type: blogs